Borel C, Sun XS, Coutte A, Bera G, et al. Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial. Radiother Oncol 2024;197:110329.
PMID: 38768714